<DOC>
	<DOC>NCT03033303</DOC>
	<brief_summary>The purpose of this study is to test see the combined effects of the study drug called Humanized 3F8 (Hu3F8) when used with granulocyte-macrophage colony stimulating factor (GM-CSF). Hu3F8 plus GM-CSF could prevent your neuroblastoma from growing, but it could also cause side effects.</brief_summary>
	<brief_title>A Study of the Effect of Hu3F8/GM-CSF Immunotherapy Plus Isotretinoin in Patients in First Remission of High-Risk Neuroblastoma</brief_title>
	<detailed_description />
	<mesh_term>Neuroblastoma</mesh_term>
	<mesh_term>Isotretinoin</mesh_term>
	<criteria>Diagnosis of NB as defined by a) histopathology (confirmed by the MSK Department of Pathology), or b) BM metastases or MIBGavid lesion(s) plus high urine catecholamine levels. Patients must have highrisk NB (MYCNamplified stage 2/3/4/4S of any age and MYCNnonamplified stage 4 in patients greater than 18 months of age). Patients must be in first CR/VGPR Existing major organ dysfunction, i.e., renal., cardiac, hepatic, neurologic, pulmonary, or gastrointestinal toxicity â‰¥ grade 3, with the exception of hearing loss and hematologic toxicity. Active lifethreatening infection. Inability to comply with protocol requirements</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Hu3F8</keyword>
	<keyword>GM-CSF</keyword>
	<keyword>Isotretinoin</keyword>
	<keyword>16-1643</keyword>
</DOC>